We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Mathematical Model Yields Clues to Sickle Cell Disease

By Biotechdaily staff writers
Posted on 16 Apr 2003
Researchers have developed a mathematical model of sickle cell disease in an effort to understand why the mutant hemoglobin proteins form long, stable scaffold-like structures that damage red blood cells rather than less harmful compact crystals.

The mutated form of hemoglobin in individuals with sickle cell disease does not remain in solution in the cytoplasm. More...
Instead, it tends to coagulate into long fibers. A sickle hemoglobin fiber can be made up of anywhere from 14 to more than 400 individual strands of hemoglobin molecules linked into long chains.

Researchers at the University of Warwick (UK) constructed the mathematical molecule to explain the stability of these fibers. The model, which was published March 28, 2003, in the online edition of Physical Review Letters, indicated that an inherent "twistiness” in the strands that comprise the fibers could be the key to their durability.

The authors proposed a possible treatment for sickle cell disease based on their model. Gene therapy might be used to introduce a hemoglobin mutant that would form less-twisty individual strands, and this could turn the fibers into less harmful crystals. Simply introducing normal hemoglobin has been shown not to work, perhaps because the few normal hemoglobin molecules cannot eliminate the fibers.



Related Links:
University of Warwick

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Immunofluorescence Analyzer
IFA System
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.